Cargando…

Hyperacute stroke thrombolysis via telemedicine: a multicentre study of performance, safety and clinical efficacy

OBJECTIVES: Timely thrombolysis of ischaemic stroke improves functional recovery, yet its delivery nationally is challenging due to shortages in the stroke specialist workforce and large geographical areas. One solution is remote stroke specialist input to regional centres via telemedicine. This stu...

Descripción completa

Detalles Bibliográficos
Autores principales: Evans, Nicholas Richard, Sibson, Lynda, Day, Diana J, Agarwal, Smriti, Shekhar, Raj, Warburton, Elizabeth A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8765016/
https://www.ncbi.nlm.nih.gov/pubmed/35039306
http://dx.doi.org/10.1136/bmjopen-2021-057372
_version_ 1784634274079571968
author Evans, Nicholas Richard
Sibson, Lynda
Day, Diana J
Agarwal, Smriti
Shekhar, Raj
Warburton, Elizabeth A
author_facet Evans, Nicholas Richard
Sibson, Lynda
Day, Diana J
Agarwal, Smriti
Shekhar, Raj
Warburton, Elizabeth A
author_sort Evans, Nicholas Richard
collection PubMed
description OBJECTIVES: Timely thrombolysis of ischaemic stroke improves functional recovery, yet its delivery nationally is challenging due to shortages in the stroke specialist workforce and large geographical areas. One solution is remote stroke specialist input to regional centres via telemedicine. This study evaluates the usage and key metrics of performance of the East of England Stroke Telemedicine Partnership—the largest telestroke service in the UK—in providing hyperacute stroke care. DESIGN: Prospective observational study. SETTING: The East of England Stroke Telemedicine Partnership provides a horizontal ‘hubless’ model of out-of-hours hyperacute stroke care to a population of 6.2 million across a 7500 square mile semirural region. PARTICIPANTS: All (2709) telestroke consultations between 1 January 2014 and 31 December 2019. MAIN OUTCOME MEASURES: Thrombolysis decision, pre-thrombolysis and post-thrombolysis stroke severity (National Institutes of Health Stroke Scale, NIHSS), haemorrhagic complications, and hyperacute pathway timings. RESULTS: Over the period, 1149 (42.4%) individuals were thrombolysed. Thrombolysis rates increased from 147/379 (38.8%) in 2014 to 225/490 (45.9%) in 2019. Median (IQR) pre-thrombolysis NIHSS was 10 (6–17), reducing to 6 (2–14) 24-hour post-thrombolysis (p<0.001). Post-thrombolysis haemorrhage occurred in 27 cases (2.3%). Over the period, median (IQR) door-to-needle time reduced from 85 (65–108) min to 68 (55–97.5) min (p<0.01), driven by improved imaging-to-needle times from 52.5 (38–72.25) min to 42 (30.5–62.5) min (p<0.01). However, the same period saw an increase in median onset-to-hospital arrival time from 77.5 (60–109.25) min to 95 (70–135) min (p<0.001). CONCLUSIONS: The results from this large hyperacute telestroke cohort indicate two important points for clinical practice. First, telemedicine via a hubless horizontal model provides a clinically effective and safe method for delivering hyperacute stroke thrombolysis. Second, improved door-to-needle times were offset by a concerning rise in prehospital timings. These findings indicate that although telemedicine may benefit in-hospital hyperacute stroke care, improvements across the whole stroke pathway are essential.
format Online
Article
Text
id pubmed-8765016
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-87650162022-02-08 Hyperacute stroke thrombolysis via telemedicine: a multicentre study of performance, safety and clinical efficacy Evans, Nicholas Richard Sibson, Lynda Day, Diana J Agarwal, Smriti Shekhar, Raj Warburton, Elizabeth A BMJ Open Neurology OBJECTIVES: Timely thrombolysis of ischaemic stroke improves functional recovery, yet its delivery nationally is challenging due to shortages in the stroke specialist workforce and large geographical areas. One solution is remote stroke specialist input to regional centres via telemedicine. This study evaluates the usage and key metrics of performance of the East of England Stroke Telemedicine Partnership—the largest telestroke service in the UK—in providing hyperacute stroke care. DESIGN: Prospective observational study. SETTING: The East of England Stroke Telemedicine Partnership provides a horizontal ‘hubless’ model of out-of-hours hyperacute stroke care to a population of 6.2 million across a 7500 square mile semirural region. PARTICIPANTS: All (2709) telestroke consultations between 1 January 2014 and 31 December 2019. MAIN OUTCOME MEASURES: Thrombolysis decision, pre-thrombolysis and post-thrombolysis stroke severity (National Institutes of Health Stroke Scale, NIHSS), haemorrhagic complications, and hyperacute pathway timings. RESULTS: Over the period, 1149 (42.4%) individuals were thrombolysed. Thrombolysis rates increased from 147/379 (38.8%) in 2014 to 225/490 (45.9%) in 2019. Median (IQR) pre-thrombolysis NIHSS was 10 (6–17), reducing to 6 (2–14) 24-hour post-thrombolysis (p<0.001). Post-thrombolysis haemorrhage occurred in 27 cases (2.3%). Over the period, median (IQR) door-to-needle time reduced from 85 (65–108) min to 68 (55–97.5) min (p<0.01), driven by improved imaging-to-needle times from 52.5 (38–72.25) min to 42 (30.5–62.5) min (p<0.01). However, the same period saw an increase in median onset-to-hospital arrival time from 77.5 (60–109.25) min to 95 (70–135) min (p<0.001). CONCLUSIONS: The results from this large hyperacute telestroke cohort indicate two important points for clinical practice. First, telemedicine via a hubless horizontal model provides a clinically effective and safe method for delivering hyperacute stroke thrombolysis. Second, improved door-to-needle times were offset by a concerning rise in prehospital timings. These findings indicate that although telemedicine may benefit in-hospital hyperacute stroke care, improvements across the whole stroke pathway are essential. BMJ Publishing Group 2022-01-17 /pmc/articles/PMC8765016/ /pubmed/35039306 http://dx.doi.org/10.1136/bmjopen-2021-057372 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Neurology
Evans, Nicholas Richard
Sibson, Lynda
Day, Diana J
Agarwal, Smriti
Shekhar, Raj
Warburton, Elizabeth A
Hyperacute stroke thrombolysis via telemedicine: a multicentre study of performance, safety and clinical efficacy
title Hyperacute stroke thrombolysis via telemedicine: a multicentre study of performance, safety and clinical efficacy
title_full Hyperacute stroke thrombolysis via telemedicine: a multicentre study of performance, safety and clinical efficacy
title_fullStr Hyperacute stroke thrombolysis via telemedicine: a multicentre study of performance, safety and clinical efficacy
title_full_unstemmed Hyperacute stroke thrombolysis via telemedicine: a multicentre study of performance, safety and clinical efficacy
title_short Hyperacute stroke thrombolysis via telemedicine: a multicentre study of performance, safety and clinical efficacy
title_sort hyperacute stroke thrombolysis via telemedicine: a multicentre study of performance, safety and clinical efficacy
topic Neurology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8765016/
https://www.ncbi.nlm.nih.gov/pubmed/35039306
http://dx.doi.org/10.1136/bmjopen-2021-057372
work_keys_str_mv AT evansnicholasrichard hyperacutestrokethrombolysisviatelemedicineamulticentrestudyofperformancesafetyandclinicalefficacy
AT sibsonlynda hyperacutestrokethrombolysisviatelemedicineamulticentrestudyofperformancesafetyandclinicalefficacy
AT daydianaj hyperacutestrokethrombolysisviatelemedicineamulticentrestudyofperformancesafetyandclinicalefficacy
AT agarwalsmriti hyperacutestrokethrombolysisviatelemedicineamulticentrestudyofperformancesafetyandclinicalefficacy
AT shekharraj hyperacutestrokethrombolysisviatelemedicineamulticentrestudyofperformancesafetyandclinicalefficacy
AT warburtonelizabetha hyperacutestrokethrombolysisviatelemedicineamulticentrestudyofperformancesafetyandclinicalefficacy